R&D Online Global 2021 R&D Online Global5312
29
June
12pm BST

MEDICINAL CHEMISTRY & BIOLOGY

Strategy Meeting Global Online 2021

Leveraging medicinal chemistry and biological perspectives that address challenges in drug discovery to stimulate R&D productivity

Facilitator Faculty

Our panel of facilitators play a key role in shaping the agenda. See who will be bringing their expertise to the 2021 Strategy Meeting:

Manel Lopez

Head of Computational Chemistry AB Science

Joseph Mancini

Head of Biology; Sr Director adMare BioInnovations

Zhihua Sui

CSO, Head of Research & Preclinical Development Proteovant Therapeutics

Klaus Dembowsky

CEO Amcure

Guido Koch

CEO Amphilix AG

Lassina Badolo

Senior Director, Head of DMPK, Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca

Jennifer Petter

Founder & CSO Arrakis Therapeutics

Werngard Czechtizky

Head, Medicinal Chemistry, RIA AstraZeneca

Peter Newham

Vp, Oncology Satefy AstraZeneca

Steve Rees

VP, Discovery Biology AstraZeneca

Ivan Cornella-Taracido

VP, Proteomics & Chemical Biology Cedilla Therapeutics

Marcie Glicksman

Head of Biology EnClear Therapies

Richard Heidebrecht

VP, R&D Glycologix

Guna Rajagopal

VP, Global Head, Computational Sciences, Discovery Sciences Janssen

Monica Schenone

Head of Chemical Biology Pfizer

Adam Gilbert

Senior Scientific Director, Design & Synthesis Sciences Pfizer

Jing Li

Executive Director PTC Therapeutics

Mark Tebbe

Co-Founder & CTO Quench Bio

Gerhard Hessler

Head of CSSD Sanofi

Deepak Rajpal

Head, Translational Sciences US Sanofi

Bill Farley

VP Sorrento Therapeutics

Reasons to Attend the Virtual Strategy Meeting

Fully Interactive Virtual Conference

We’re all bored of the same webinar format by now. Instead, join intimate groups of like-minded professionals and discuss the topics that really matter to you

Personalised and Easy to Join Agenda

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we will send you the direct links and calendar reminder to join

Senior Decision Makers

All our roundtable discussions are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Private and Intimate Discussions

Each sessions is read by an industry expert and the roundtables are limited to ensure you have fruitful and genuine conversations with your colleagues

Agenda

See Which Topics Are Up For Discussion

7:00 ET


Effective strategies towards implementing AI in Medicinal Chemistry to optimize clinical success Werngard Chechtizky — Head of Medicinal Chemistry, AstraZeneca Jennifer Petter — Founder & CSO, Arrakis Therapeutics Thierry Lave — Global Head DMPK & TOX Project Leaders and Modeling & Simulation, Roche
09:00 ET


A MultiDisciplinary Approach to Facilitating Collaborative Discovery Samantha Jeschonek, Ph.D, Product Manager, Collaborative Drug Discovery

Who Should Attend Our Medicinal Chemistry Strategy Meetings

VP/Dir/Head Medicinal Chemistry

Head of Chemistry

Head of Quality

Head of research

Head of Discovery

Scientific Director

CSO/CMO/CTO/CEO

Computational Chemistry

Senior Scientist/Investigator

External Innovation

VP of Biology

Medical Director

Director Structural and Physical Sciences

Director of Research Strategy

Head of Computational Biology

Lab Head

Our 2021 Lead Sponsor

Our 2021 Co-Hosts

Our 2021 Key Opinion Leader

Quick Links

See what’s next

Check out the full Strategy Meeting agenda or find out more about upcoming events.